Pore-forming proteins and their role in cancer and inflammation: Mechanistic insights and plausible druggable targets
dc.contributor.author | Sankar, Jishnu | |
dc.contributor.author | Arora, Sahil | |
dc.contributor.author | Joshi, Gaurav | |
dc.contributor.author | Kumar, Raj | |
dc.date.accessioned | 2024-01-21T10:38:24Z | |
dc.date.accessioned | 2024-08-13T12:05:20Z | |
dc.date.available | 2024-01-21T10:38:24Z | |
dc.date.available | 2024-08-13T12:05:20Z | |
dc.date.issued | 2022-08-30T00:00:00 | |
dc.description.abstract | Perforin is a granular effector pore-forming protein formed in NK cells and Cytotoxic T lymphocytes. These cytotoxic proteins are part of the first-line immune defense in the human body. They ensure apoptosis of pathogen-infected cells or tumor cells in the human body. Activation of receptors on NK cell or T cell triggers secondary proteins in these cells. Further, it leads to Ca2+ dependent perforin egress towards the target cell, ensued by PI3K signaling pathway. Perforin undergoes oligomerization over the target cell membrane and forms transmembrane pores with the membrane-spanning domain-MACPF domain. Granzymes, proapoptotic serine proteases are released through these pores and initiate the target cell apoptotic pathway leading to the cell death. Although perforin is a savior for humans from tumor and viral infections, uncontrolled expression of the perforins leads to the autoimmune conditions, including Familial Hemophagocytic lymphohistiocytosis, insulin-dependent diabetes, and cerebral myocarditis. The present review is the concerted effort to highlight the mechanistic pathways concerning perforin secretion, NK cell and T cell-mediated cytotoxicity towards virus-infected and transformed cells. This is followed by the discussion on synthetic derivatives tested so far to inhibit the perforin in pre and clinical arena for certain unusual conditions. � 2022 Elsevier B.V. | en_US |
dc.identifier.doi | 10.1016/j.cbi.2022.110127 | |
dc.identifier.issn | 92797 | |
dc.identifier.uri | https://kr.cup.edu.in/handle/32116/3560 | |
dc.identifier.url | https://linkinghub.elsevier.com/retrieve/pii/S0009279722003325 | |
dc.language.iso | en_US | en_US |
dc.publisher | Elsevier Ireland Ltd | en_US |
dc.subject | Cancer | en_US |
dc.subject | Drug development | en_US |
dc.subject | Immunology | en_US |
dc.subject | Killer cells | en_US |
dc.subject | Perforins | en_US |
dc.title | Pore-forming proteins and their role in cancer and inflammation: Mechanistic insights and plausible druggable targets | en_US |
dc.title.journal | Chemico-Biological Interactions | en_US |
dc.type | Review | en_US |
dc.type.accesstype | Closed Access | en_US |